INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Oncology Clinical Trials Key Considerations: Planning For Success
Chief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.
-
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling
See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
Why Early CRO Choice Is Critical To Accelerating Delivery Of Your Clinical Program
Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.
-
Finding The Right CRO Partner For Early-Stage Oncology Trials
Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
-
When Your Protocol Includes Ocular Endpoints4/6/2026
Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
-
From Legacy To Lifeline: Advancing Rare Disease Care6/13/2025
Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.
-
The Real Power Of Digital Payments In Clinical Trials10/8/2025
Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.
-
Building A Gold Standard Trial Experience In Japan4/4/2025
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
A Guide To Patient Reimbursements And Payments9/13/2024
Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Maximize growth with strategic site selection and incentives advisory that help reduce project costs and optimize expansion, unlocking long-term business value.
-
Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.
-
Discover a debit card designed for clinical trials, providing participants with fast, reliable payments and giving sites and sponsors clear systems that help minimize burden and improve retention.
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.